FIELD: chemistry.
SUBSTANCE: invention relates to biochemistry and biotechnology and can be used in the pharmaceutical industry to produce drugs for treating conditions, which involves inhibiting dipeptidyl peptidase IV (DPPIV). Proposed is use of the disclosed inhibitors as a means of suppressing the function of DIPPIV through direct administration thereof and as part of a pharmaceutical composition.
EFFECT: obtaining a group of novel peptides, having DIPPIV inhibitor properties, which enable to reduce enzyme activity by at least 25%.
9 cl, 1 tbl, 11 dwg, 5 ex
